ECDC and EMCDDA technical guidance on prevention and control of infectious diseases among people who inject drugs
The content of this joint guidance was developed by the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) with the support of a technical advisory group composed of policy makers, service providers, civil society representatives and preventative health experts from throughout the EU/EEA.
ECDC and EMCDDA technical guidance on prevention and control of infectious diseases among people who inject drugs - guidance in brief
This evidence-based guidance is designed to inform the development, monitoring and evaluation of national strategies and programmes in countries in Europe in order to reduce and prevent infections among people who inject drugs.
Tuberculosis - 85% can save lives
Tuberculosis treatment outcome remains a challenge in the European Union. The European Centre for Disease Prevention and Control highlights that not achieving the treatment success target of 85% could have an impact on human lives saved and the financial resources needed for tuberculosis control in the European Union and beyond.
Public health guidance: Seasonal influenza vaccination of children and pregnant women
The aim of this guidance document is to provide EU/EEA Member States and EU bodies with relevant information to make an informed decision on routine vaccination of healthy children and pregnant women with seasonal influenza vaccine. The options presented in this document are based on a systematic review of the literature and the opinions of a group of independent experts.
Infectious diseases among travellers and migrants in Europe, Eurotravnet 2010
Gautret, P., Cramer, J.P., Field, V., Caumes, E., Jensenius, M., Gkrania-Klotsas, E., de Vries, P.J., Grobusch, M.P., Lopez-Velez, R., Castelli, F., Schlagenhauf, P., Hervius, Askling, H., Von Sonnenburg, F., G, Lalloo, D., Loutan, L., Rapp, C., Basto, F., Santos, O'Connor, F., Weld, L., Parola, P.
The disease burden of hepatitis B, influenza, measles and salmonellosis in Germany: first results of the Burden of Communicable Diseases in Europe Study.
Plass, D., Mangen, M.J., Kraemer, A., Pinheiro, P., Gilsdorf, A., Krause, G., Gibbons, C.L., van Lier, A., McDonald, S.A., Brooke, R.J., Kramarz, P., Cassini, A., Kretzschmar, M.E.
Cost-effectiveness analysis of programmatic screening strategies for latent tuberculosis infection in the EU/EEA
The elimination of tuberculosis (TB) in Europe will require the management of latent tuberculosis infection (LTBI) in key populations. Management of LTBI requires the identification and adequate treatment of infected people. It is currently unknown how screening and treatment of key populations should be best organised to have the highest impact with the available resources.
Social determinants and risk factors in tuberculosis surveillance in the EU/EEA
The objective of this report is to provide countries with advice on what social determinant and risk factor variables to collect and what definitions to use, and to propose information to be collected at the national and European level.
Aiming for zero tuberculosis transmission in low-burden countries
Marais, B.J., Walker, T.M., Cirillo, D.M., Raviglione, M., Abubakar, I., van der Werf, M.J., Boehme, C., Niemann, S., Castro, K.G., Zumla, A., Sintchenko, V., Crook, D.W.